Trial: 201411046

Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy versus Conventional Photon Irradiation with Concomitant and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma (BN001)

Phase

II

Principal Investigator

Huang, Jiayi

Disease Site

Brain and Nervous System

Learn more about this study at: clinicaltrials.gov